Journal of Enzyme Inhibition and Medicinal Chemistry · 2010 · 19 citations · 29 references
MedicineMedicinal ChemistryPharmacologyDrug DesignEnzymologyNeuropharmacologyCholinergic NeurochemistryCholinergic PharmacologyEnzyme InhibitionStructure-activity Relationship AnalysisAcetylcholinesterase InhibitorsAnticholinergic DrugsChemical Enzyme InhibitorsDrug LipophilicityHalf-maximal Inhibitory ConcentrationMixed-type InhibitorsSteric ConstraintsUncompetitive Inhibition
Some new α-aminomethylenephosphonic acids 1-11 were synthesised and characterised by (1)H, (13)C, (31)P NMR, IR spectroscopy and elemental analysis. The potencies of these compounds to inhibit human erythrocyte acetylcholinesterase (hAChE, EC 3.1.1.7) were studied by a modified Ellman's method. In addition, the log P values were computed by Hyperchem software. Here, alendronate was used as a reference inhibitor. Results showed that the IC(50) values ranged from 9.11 to 28.72 mM. The half maximal inhibitory concentration (IC(50)) value decreased with an increasing number of carbon atoms of the amine group in compounds 1-5. Also, in most cases, increasing the number of carbon atoms led to enhancement of the toxicity as predicted by the log P values. Using Lineweaver-Burk and Dixon analysis, it was indicated that compounds 1-10 are mixed inhibitors while compound 11 is a coupling or uncompetitive inhibitor. The results showed that the electronic changes have ignorable effects, steric influence is important in some cases, but the lipophilicity parameter is the most significant factor in hAChE inhibition by bisphosphonates.
29
A new and rapid colorimetric determination of acetylcholinesterase activity
George L. Ellman, K. Diane Courtney, Valentino Andres et al. · Biochemical Pharmacology · 1961 · 26.9K citations
Vγ2Vδ2 T-cell receptor–mediated recognition of aminobisphosphonates
Hiranmoy Das, Lisheng Wang, Arati B. Kamath et al. · Blood · 2001 · 174 citations · Full text